share_log

XINGTONG SHIPPING(603209):1H24 RESULTS BEAT; GROSS MARGIN OF DOMESTIC AND OVERSEAS BUSINESSES RISES MARKEDLY

XINGTONG SHIPPING(603209):1H24 RESULTS BEAT; GROSS MARGIN OF DOMESTIC AND OVERSEAS BUSINESSES RISES MARKEDLY

興通運輸(603209):1H24業績超預期;國內外業務的毛利率顯著上升。
中金公司 ·  08/13

1H24 results beat our expectations

成交量超出我們的預期

Xingtong Shipping announced its 1H24 results: Revenue rose 24% YoY to Rmb772mn and net profit attributable to shareholders grew 32% YoY to Rmb180mn, implying EPS of Rmb0.64. In 2Q24, revenue rose 35% YoY and +0% QoQ to Rmb387mn, and net profit attributable to shareholders grew 71% YoY and 33% QoQ to Rmb103mn, beating our expectations.

星通航運宣佈其1H24年度業績:營業收入同比增長24%至7.72億元人民幣,淨利潤同比增長32%至1.8億元人民幣,每股收益爲0.64人民幣。在2Q24年度,收入同比增長35%,環比持平,達到3.87億元人民幣,淨利潤同比增長71%,環比增長33%至1.03億元人民幣,超出我們的預期。

We attribute the strong results to higher-than-expected growth in time charter income driven by overseas business expansion. In 1H24, domestic revenue was Rmb480mn (accounting for 62% of total revenue) with gross margin at 40.7% (up 4.7ppt from 36.1% in 2023); overseas revenue was Rmb292mn (accounting for 38%) with gross profit margin at 29.8% (up 4.9ppt from 24.9% in 2023).

我們將強大的業績歸因於海外業務擴展帶來超出預期的時間租船收益增長。在1H24年度,國內營收爲4.8億元人民幣(佔總收入的62%),毛利率爲40.7%(較2023年的36.1%提高了4.7個百分點);境外營收爲2.92億元人民幣(佔總收入的38%),毛利率爲29.8%(較2023年的24.9%提高了4.9個百分點)。

Trends to watch Expansion of shipping capacity as expected: Share of domestic shipping market rising steadily; shipping orders related to foreign trade ample.

趨勢關注:船舶容量擴大符合預期:國內船運市場份額穩步上升;涉外貿易航運訂單充足。

Based on data from shipformula.com, the firm estimates that its share measured by total volume of liquid chemicals transported for domestic trade rose to 15.49% from 13.95% at end-2023. In the domestic trade market, we believe the firm may continue to step up efforts to assess new shipping capacity and acquire capacity from other institutions to expand its fleet at an appropriate pace, stabilize its leading position, and gradually increase its market share.

根據shipformula.com的數據,該公司按液體化學品運輸的總體積測算,其在國內貿易市場上的份額從2023年底的13.95%上升到15.49%。在國內貿易市場上,我們相信該公司可能會繼續加大努力評估新的船舶容量,並從其他機構中收購容量,以適當的速度擴大其船隊,穩定其領先地位,並逐步提高市場份額。

The firm announced that the shipping capacity of its vessels for various bulk and hazardous liquefied cargos rose 7% from end-2023 to 410,000 DWT (35 vessels for foreign trade of chemicals, with two being newly added). The firm has nine chemical vessels under construction with a combined shipping capacity of 153,800 DWT (37,200 DWT for domestic trade and 116,600 DWT for foreign trade). As new vessels come online, we expect the firm's overseas business to drive revenue growth.

該公司公佈的各種散裝和危險液態貨物船舶的航運能力比2023年底增長了7%,達到了41萬噸(涉外貿易化學品航運船共35艘,其中兩艘是新加入的)。該公司有9艘化學船正在建造中,其總航運能力爲15.38萬噸(其中國內貿易船舶37,200噸,涉外貿易船舶116,600噸)。隨着新船的上線,我們預計該公司的境外業務將推動收入增長。

2Q24 gross margin improves notably YoY and QoQ; watch domestic trade demand and changes in foreign trade business. In 2Q24, the firm's gross margin rose 8.8ppt YoY and 8.7ppt QoQ to 40.9%, and its net margin rose 5.6ppt YoY and 6.5ppt QoQ to 26.6%. Domestic trade demand is still recovering. The firm's business related to domestic trade has rebounded YoY thanks to a low base for comparison. Looking ahead, we expect gross margin of this business to be boosted thanks to improving operating efficiency. We believe gross margin of foreign trade-related business may gradually improve as new ships come online, the firm expands its business scale, and its operating experience becomes increasingly rich.

2Q24年度毛利率同比和環比分別增長了8.8個和8.7個百分點,淨利率同比增長了5.6個和6.5個百分點,關注國內貿易需求和涉外貿易業務的變化。國內貿易需求仍在恢復中。該公司與國內貿易相關的業務由於基數較低,同比回升。展望未來,我們預計該業務的毛利率將因提高運營效率而提高。我們認爲,隨着新船的上線,該公司的涉外貿易相關業務的毛利率可能逐步提高,其業務規模擴大,運營經驗越來越豐富。

Financials and valuation

財務和估值。

As the firm's overseas business expansion is better than we expected, we raise our earnings forecast 13% to Rmb341mn for 2024 and 18% to Rmb431mn for 2025. The stock is trading at 11.9x and 9.4x 2024e and 2025e P/E. We maintain an OUTPERFORM rating and our TP of Rmb19.5, implying 16.0x 2024e and 12.7x 2025e P/E, offering 34.5% upside.

由於該公司的海外業務擴張優於我們的預期,我們將其2024年度盈利預測上調13%至3.41億元人民幣,2025年度上調18%至4.31億元人民幣。該股票的2024年度和2025年度市盈率爲11.9倍和9.4倍。我們維持它的跑贏大市評級並保持目標價19.5元人民幣,暗示2024年度和2025年度市盈率分別爲16.0倍和12.7倍,提供34.5%的上行空間。

Risks

風險

Output growth of upstream chemicals slows; capacity expansion disappoints; geopolitical risks weigh on foreign trade.

上游化學品產量增長放緩;擴大產能令人失望;地緣政治風險對涉外貿易造成壓力。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論